Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Greiner Website

John W. Greiner, Ph.D.

Selected Publications

1)  Takai S, Schlom J, Tucker J, Tsang KY, Greiner JW.
Inhibition of TGF-ß1 Signaling Promotes Central Memory T Cell Differentiation.
J. Immunol. 2013.
[Journal]
2)  Zaharoff DA, Heffernan M, Fallo J, Greiner JW.
Sarmento B, das Neves J, eds.
Preclinical and clinical use of chitosan and derivatives for biopharmaceuticals from preclinical research to the bedside (Chapter 27). In: Chitosan-based Systems for Biopharmaceuticals: Delivery, Targeting and Polymer Therapeutics.
New York: John Wiley & Sons; 2012. p. 525-541 [Book Chapter]
3)  Takai S, Sabzevari H, Farsaci B, Schlom J, Greiner JW.
Distinct effects of saracatinib on memory CD8+ T cell differentiation.
J. Immunol. 188: 4323-33, 2012.
[Journal]
4)  Heffernan MJ, Zaharoff DA, Fallon JK, Schlom J, Greiner JW.
In vivo efficacy of a chitosan/IL-12 adjuvant system for protein-based vaccines.
Biomaterials. 32: 926-32, 2011.
[Journal]
5)  Bonmassar L, Fossile E, Scoppola A, Graziani G, Prete SP, Formica V, Cappelletti D, De Vecchis L, Cardillo A, Concolino F, D'Atri S, Balduzzi A, Torino F, Caporaso P, Greiner JW, Bonmassar E, Roselli M, Aquino A.
Detection of circulating tumor cells is improved by drug-induced antigen up-regulation: preclinical and clinical studies.
Anticancer Res. 30: 4721-30, 2010.
[Journal]
6)  Zaharoff DA, Hance KW, Rogers CJ, Schlom J, Greiner JW.
Intratumoral Immunotherapy of Established Solid Tumors With Chitosan/IL-12.
Journal of immunotherapy (Hagerstown, Md. : 1997). 33: 697-705, 2010.
[Journal]
7)  Zaharoff DA, Hoffman BS, Hooper HB, Benjamin Jr CJ, Khurana KK, Hance KW, Rogers CJ, Pinto PA, Schlom J, Greiner JW.
Intravesical immunotherapy of superficial bladder cancer with chitosan/IL-12.
Cancer Res. 69: 6192-9, 2009.
[Journal]
8)  Hance KW, Rogers CJ, Zaharoff DA, Canter D, Schlom J, Greiner JW.
The antitumor and immunoadjuvant effects of IFN-alpha in combination with recombinant poxvirus vaccines.
Clin. Cancer Res. 15: 2387-96, 2009.
[Journal]
9)  Rogers CJ, Berrigan D, Zaharoff DA, Hance KW, Patel AC, Perkins SN, Schlom J, Greiner JW, Hursting SD.
Energy restriction and exercise differentially enhance components of systemic and mucosal immunity in mice.
J. Nutr. 138: 115-22, 2008.
[Journal]
10)  Rogers CJ, Zaharoff DA, Hance KW, Perkins SN, Hursting SD, Schlom J, Greiner JW.
Exercise enhances vaccine-induced antigen-specific T cell responses.
Vaccine. 2008.
[Journal]
Click Here to View Expanded Bibliography.

This page was last updated on 8/19/2013.